Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple Sclerosis.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Multiple sclerosis simulating brain tumor.
Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.
Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue.
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis.
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
Idiopathic inflammatory demyelinating disorders of the central nervous system in children.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis.
Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
Current standards of treatment in ms and the role of oral agents.
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes.
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
CXXC5 plays a role as a transcription activator for myelin genes on oligodendrocyte differentiation.
[Vitamin D in Multiple Sclerosis].
Pages
« first
‹ previous
…
490
491
492
493
494
495
496
497
498
…
next ›
last »